Pharmacists' contributions to the management of opioid use disorder
Authors:
- Paul M. StrangesPSPaul M. Stranges
- Kathleen K. AdamsKAKathleen K. Adams
- Abigail T. Elmes‐PatelAEAbigail T. Elmes‐Patel
- Alexander F. InfanteAIAlexander F. Infante
- Angela KerinsAKAngela Kerins
- Qing MaQMQing Ma
- Lyndsi K. MeyenburgLMLyndsi K. Meyenburg
- Cecilia NymanCNCecilia Nyman
- Golden L. PetersGPGolden L. Peters
- 3 June 2025
- journal article
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 8 (6) , 500-510
Abstract
Clinicians continue to work toward ending the opioid‐related overdose and death epidemic in the United States. Opioid use disorder (OUD) is a chronic and relapsing disease characterized by an overpowering desire to use opioids despite serious adverse effects, impairment, or distress. Management of OUD requires team‐based care. Pharmacists are uniquely positioned to contribute to the management of OUD in all stages and have demonstrated positive outcomes. Pharmacists are the most accessible health care professionals in community settings, and they practice in all settings across the health care continuum. However, opportunities exist to bridge the disparity between the demand for treatment and its availability. Regulatory barriers limit innovation and expansion of pharmacy services. This white paper describes pharmacists' contributions to the management of OUD and identifies opportunities to leverage pharmacists within the health care landscape to improve patient outcomes.Keywords
This publication has 84 references indexed in Scilit:
- The Importance of Treating Opioid Use Disorder in PregnancyJAMA Internal Medicine, 2024
- Trends in Before Medically Advised Discharges for Patients With Opioid Use Disorder, 2016-2020JAMA, 2023
- Use of Medication for Opioid Use Disorder Among Adults With Past-Year Opioid Use Disorder in the US, 2021JAMA Network Open, 2023
- High-Dose Buprenorphine Initiation in the Emergency Department Among Patients Using Fentanyl and Other OpioidsJAMA Network Open, 2023
- Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019JAMA Network Open, 2022
- High-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use DisorderJAMA Network Open, 2021
- Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017JAMA, 2021
- Association of Treatment With Medications for Opioid Use Disorder With Mortality After Hospitalization for Injection Drug Use–Associated Infective EndocarditisJAMA Network Open, 2020
- Association of Hospital Discharge Against Medical Advice With Readmission and In-Hospital MortalityJAMA Network Open, 2020
- Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid DependenceJAMA, 2015